Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients
Clinical trial NCT06234072 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06234072
- Sponsor
- Shenzhen University General Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2027-01-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.